Eli Dahan’s Movment Offers 100 Million Shekels to Gain Control of Novolog Pharma Distributor

Movment, led by Eli Dahan, has submitted a purchase offer to acquire 21.34% of Novolog, a pharmaceutical distribution company, for 100 million shekels. The offer values Novolog shares at 72.14 shekels each, a 5% premium over the closing price on the Tel Aviv Stock Exchange, and is valid until August 5. Dahan previously held 11% of Novolog privately, signaling Movment’s clear intention to take control of the company.

Novolog was founded by Ehud Pozis, who remains a key figure but holds no official position. The company’s chairman is Arik Shor and CEO is Aviad Busi. Since the start of the year, Novolog’s share price has dropped 44%, reaching its lowest level. The company reported a profit of approximately 4.5 million shekels in 2025 and a modest profit of 200,000 shekels in the first quarter.

Movment recently secured a 100 million shekel investment from Leumi Partners, valuing the group at 500 million shekels. Movment operates as a wellness group owning several businesses, including the Bash-Gal retail chain and Energems, and has recently acquired control of Wonder Care, a paramedical treatment company.